IL213589A0 - DIPYRIDO [2,3-d;4-d] PYRROL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

DIPYRIDO [2,3-d;4-d] PYRROL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
IL213589A0
IL213589A0 IL213589A IL21358911A IL213589A0 IL 213589 A0 IL213589 A0 IL 213589A0 IL 213589 A IL213589 A IL 213589A IL 21358911 A IL21358911 A IL 21358911A IL 213589 A0 IL213589 A0 IL 213589A0
Authority
IL
Israel
Prior art keywords
dipyrido
preparation
pharmaceutical compositions
compositions containing
pyrrol derivatives
Prior art date
Application number
IL213589A
Other versions
IL213589A (en
Original Assignee
Brugger Nadia
Jones Christopher Charles Victor
Merck Patents Gmbh
Sutton E Amanda
Askew Jr Benny C
Huck Bayard R
Smith Garry R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brugger Nadia, Jones Christopher Charles Victor, Merck Patents Gmbh, Sutton E Amanda, Askew Jr Benny C, Huck Bayard R, Smith Garry R filed Critical Brugger Nadia
Publication of IL213589A0 publication Critical patent/IL213589A0/en
Publication of IL213589A publication Critical patent/IL213589A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL213589A 2008-12-18 2011-06-16 Dipyrido [2,3-d;4-d] pyrrol derivatives, their preparation and pharmaceutical compositions containing them IL213589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20302208P 2008-12-18 2008-12-18
PCT/US2009/066534 WO2010080253A1 (en) 2008-12-18 2009-12-03 Tricyclic azaindoles

Publications (2)

Publication Number Publication Date
IL213589A0 true IL213589A0 (en) 2011-07-31
IL213589A IL213589A (en) 2016-02-29

Family

ID=41682740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL213589A IL213589A (en) 2008-12-18 2011-06-16 Dipyrido [2,3-d;4-d] pyrrol derivatives, their preparation and pharmaceutical compositions containing them

Country Status (8)

Country Link
US (1) US8853391B2 (en)
EP (1) EP2367822B1 (en)
JP (2) JP2012512871A (en)
AU (1) AU2009336040B2 (en)
CA (1) CA2745085C (en)
ES (1) ES2603208T3 (en)
IL (1) IL213589A (en)
WO (1) WO2010080253A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102939282B (en) * 2010-04-16 2015-12-02 Ac免疫有限公司 Be used for the treatment of the compound of the disease relevant with amyloid or amyloid-like protein
WO2014159802A1 (en) * 2013-03-14 2014-10-02 Bristol-Myers Squibb Company Bicyclo [2.2.2] acid gpr120 modulators
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
US10633383B2 (en) 2018-01-05 2020-04-28 Ac Immune Sa Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregates
CA3086759A1 (en) * 2018-01-05 2019-07-11 Ac Immune Sa 1,3,4,5-tetrahydro-2h-pyrido[4,3-b]indole derivatives for the treatment, alleviation or prevention of disorders associated with tau aggregates like alzheimer's disease
EA202091395A1 (en) * 2018-06-04 2020-10-01 Ас Иммьюн Са DERIVATIVES OF 1,3,4,5-TETRAHYDRO-2H-PYRIDO [4,3-b] INDOL FOR TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES SUCH AS ALZHEIMER'S DISEASE
EP3802528B1 (en) * 2018-06-04 2022-07-06 AC Immune SA Novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates
CA3131805C (en) 2019-03-01 2023-11-21 Ac Immune Sa Novel compounds for the treatment, alleviation or prevention of disorders associated with tau aggregates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268771A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd Azacarbazoles
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
TR199801530T2 (en) 1996-02-13 1998-11-23 Zeneca Limited Quinazoline derivatives as VEGF inhibitors.
JP4464466B2 (en) 1996-03-05 2010-05-19 アストラゼネカ・ユーケイ・リミテッド 4-anilinoquinazoline derivatives
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
US6589954B1 (en) * 1998-05-22 2003-07-08 Scios, Inc. Compounds and methods to treat cardiac failure and other disorders
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
WO2001092224A1 (en) 2000-05-31 2001-12-06 Astrazeneca Ab Indole derivatives with vascular damaging activity
BR0112225A (en) 2000-07-07 2003-05-06 Angiogene Pharm Ltd Compound, pharmaceutical composition, use of a compound, and process for preparing a compound
IL153484A0 (en) 2000-07-07 2003-07-06 Angiogene Pharm Ltd Colchinol derivatives as angiogenesis inhibitors
US20040014676A1 (en) * 2001-07-09 2004-01-22 Ramalinga Dharanipragada SRC kinase inhibitors useful for treating osteoporosis
FR2891459B1 (en) * 2005-09-30 2007-12-28 Flamel Technologies Sa MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE INGREDIENT AND ORAL GALENIC FORM COMPRISING THE SAME
US8119655B2 (en) * 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2010500961A (en) * 2006-08-02 2010-01-14 武田薬品工業株式会社 α-carboline derivative and method for producing the same
AU2008269513B2 (en) * 2007-06-26 2011-06-16 Astrazeneca Ab 1-cyanocyclopropyl-derivatives as cathepsin K inhibitors
RU2007139634A (en) * 2007-10-25 2009-04-27 Сергей Олегович Бачурин (RU) NEW THIAZOLE-, TRIAZOLE- OR OXADIAZOLE-CONTAINING TETRACYCLIC COMPOUNDS

Also Published As

Publication number Publication date
EP2367822A1 (en) 2011-09-28
US8853391B2 (en) 2014-10-07
CA2745085A1 (en) 2010-07-15
JP2012512871A (en) 2012-06-07
US20120022060A1 (en) 2012-01-26
EP2367822B1 (en) 2016-10-05
JP2015187155A (en) 2015-10-29
WO2010080253A1 (en) 2010-07-15
AU2009336040B2 (en) 2015-07-16
JP6109880B2 (en) 2017-04-05
CA2745085C (en) 2018-03-06
ES2603208T3 (en) 2017-02-24
IL213589A (en) 2016-02-29
AU2009336040A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
IL213589A0 (en) DIPYRIDO [2,3-d;4-d] PYRROL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL213993A (en) 1,2,3,4-tetrahydropyrido[2,3-b]pyrazine-2-one derivatives and pharmaceutical compositions comprising them
IL220432A (en) Thieno[2,3-b]pyridinedione derivatives and pharmaceutical compositions comprising the same
PT3012258T (en) Pharmaceutical composition comprising a pyrazolo[1,5-a]pyrimidine derivative as an antiviral agent
IL200695A (en) Hydrooxazolo[3,2-a]pyrimidin-7-one derivatives and pharmaceutical compositions comprising the same
IL211693A (en) 3-cyano-6-( amino substituted)-8-( amino optionally substituted)-imidazo[l,2-b]pyridazine derivatives and pharmaceutical compositions comprising them
IL193141A (en) Pyrrolo[2,3-d]pyrimidine-7 -yl-containing sulfamate compounds, pharmaceutical compositions comprising them and uses thereof
IL219424A (en) Imidazo [1,2-b] pyridazine derivatives, combinations, products, pharmaceutical compositions comprising them and process for their preparation and their use as pde10 inhibitors
ZA201004823B (en) Novel pyrazolo [3,4-d]pyrimidine derivatives as anti-cancer agents
IL215911A (en) 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives, pharmaceutical compositions comprising them and processes for their preparation and their use in the preparation of medicaments
HK1164292A1 (en) Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
HK1143154A1 (en) Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors b[23-d]
ZA201100429B (en) Novel imidazo [1,2-a]pyrimidine derivatives,method for the preparation thereof,use thereof as medicaments,pharmaceutical compositions and novel use in particular as met inhibitors
IL205189A (en) 6,7-dihydro-5h-imidazo[1,2-α]imidazole-3-carboxamide derivatives and pharmaceutical compositions comprising them
HK1169388A1 (en) 6,7,8,9-tetrahydro-pyrimido1,2-a pyrimidin-4-one derivatives, their preparation and pharmaceutical use thereof 6789-12-a -4-
IL210074A (en) Process for the preparation of derivatives of pyrido[2,3-d]pyrimidine-7-yl-phenyl
IL219371A (en) Ethynyl-(s-triazolo/pyrazolo)[1,5-a](pyridine/ pyrimidine) derivatives and pharmaceutical compositions comprising them
SG10201403138WA (en) Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof and pharmaceutical use thereof
IL212942A (en) Rifamycin derivatives, process for their preparation, pharmaceutical compositions comprising the same and uses thereof
EP2139333A4 (en) Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators
IL206673A0 (en) Imidazo[1,2-a]pyridine-2-carboxamide derivatives, their preparation and their therapeutic application
IL205710A (en) Spiro[piperidine-benzopyran] derivatives, pharmaceutical compositions comprising them, process for their preparation and uses thereof
EP2139332A4 (en) Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
IL210377A (en) Naphthyridone derivatives, their preparation and pharmaceutical compositions containing them
IL206671A0 (en) N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed